LiveZilla Live Chat Software

Constellation, le dépôt institutionnel de l'Université du Québec à Chicoutimi

Strength-Training Induces Skeletal Muscle Adaptations in Patients with Myotonic Dystrophy Type I: A Case Study

Roussel Marie-Pier, Morin Marika, Petitclerc Émilie, Fortin Anne-Marie, Gagnon Cynthia, Hébert Luc J., Leone Mario et Duchesne Élise. (2016). Strength-Training Induces Skeletal Muscle Adaptations in Patients with Myotonic Dystrophy Type I: A Case Study. Medicine & Science in Sports & Exercise, 48, (5S), p. 641.

[img] PDF
Administrateurs seulement

99kB

URL officielle: https://doi.org/10.1249/01.mss.0000486923.39242.9a

Résumé

PURPOSE: Myotonic dystrophy type 1 (DM1) is the most prevalent inherited neuromuscular disease in adults. This multisystemic disease is characterized by skeletal muscle impairments including muscle wasting. Slowing muscle wasting in this population using strength training seems a promising strategy, but it remains unknown if it would trigger cellular and molecular responses similar to the ones observed in healthy people. The objective of this case study is to evaluate the effect of a strength-training program on skeletal muscle adaptations in a DM1 patient.

METHODS: One male with DM1 (age = 36) underwent a 12-week strength-training program, twice a week, consisting of 2 sets of 6 exercises at 6 RM supplemented by functional tasks. Vastus lateralis muscle biopsy samples were obtained pre- and post-training program. The proportion of type I and II myofibers and the cross sectional area (CSA) of each type were determined by immunohistochemistry. The percentage of centrally nucleated fibers (CNF) was obtained following staining with hematoxyline/eosine Two blinded evaluators analyzed the data.

RESULTS: Following the 12-week strength-training program, the patient showed an increase in the CSA of type I myofibers evaluated at 46% (p<0.05) by evaluator #1 and 51% (p<0.05) by evaluator #2. For type II myofibers, the increase in CSA was evaluated to 24% (p<0.05) and 29% (p<0.05) by evaluator #1 and #2, respectively. A muscle fiber-type switching was also induced by the 12-week strength-training program as shown by the increase in the proportion of type II myofibers from 29% to 71% (p<0.05) noted by the evaluator #1 and the similar observation noted by evaluator #2 (28% to 72%, p<0.05). No change was observed in the percentage of CNF by both evaluators.

CONCLUSIONS: Our results suggest that skeletal muscle of patients with DM1 could undergo adaptations linked to muscle growth as demonstrated by the increase in the CSA of type I and type II myofibers. It also seems that strength-training parameters used in this study could also influence the distribution of myofibers, in favour of type II. Further studies comprising a higher number of participants are needed to validate our findings and determine to which extent and how skeletal muscles of patients with DM1 adapt to strength training stimulus.

Type de document:Article publié dans une revue avec comité d'évaluation
Volume:48
Numéro:5S
Pages:p. 641
Version évaluée par les pairs:Oui
Date:2016
Sujets:Sciences de la santé
Sciences de la santé > Sciences de l'activité physique et réadaptation
Sciences de la santé > Sciences de l'activité physique et réadaptation > Physiothérapie
Département, module, service et unité de recherche:Départements et modules > Département des sciences de la santé > Unité d'enseignement en physiothérapie
Mots-clés:Myotonic Dystrophy Type 1, DM1, strenght-training, neuromuscular disease, skeletal muscle, adapation
Déposé le:14 mars 2019 00:27
Dernière modification:14 mars 2019 00:27
Afficher les statistiques de telechargements

Éditer le document (administrateurs uniquement)

Creative Commons LicenseSauf indication contraire, les documents archivés dans Constellation sont rendus disponibles selon les termes de la licence Creative Commons "Paternité, pas d'utilisation commerciale, pas de modification" 2.5 Canada.

Bibliothèque Paul-Émile-Boulet, UQAC
555, boulevard de l'Université
Chicoutimi (Québec)  CANADA G7H 2B1
418 545-5011, poste 5630